MARILYN ROBERTS: Open Payments
NPI 1811463490 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,005 in 74 payments from 15 companies in 2025. Trend: 2023 $1,364 · 2024 $1,388 · 2025 $2,005
Food & beverage: $1,830Education: $175
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $294 |
| UCB, Inc. | 13 | $291 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $256 |
| Novartis Pharmaceuticals Corporation | 14 | $255 |
| E.R. Squibb & Sons, L.L.C. | 7 | $203 |
| ABBVIE INC. | 8 | $192 |
| Janssen Biotech, Inc. | 6 | $167 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| Regeneron Healthcare Solutions, Inc. | 4 | $91 |
| Galderma Laboratories, L.P. | 2 | $38 |
Products named: DUPIXENT, Bimzelx, COSENTYX, Sotyktu, TREMFYA, Winlevi, RINVOQ, SKYRIZI.
Industry payments across GA — which companies pay providers there.
